Literature DB >> 27162744

Retinal toxicity with Ritonavir.

Yufei Tu1, Ronald J Poblete1, Benjamin D Freilich1, Marco A Zarbin1, Neelakshi Bhagat1.   

Abstract

Entities:  

Year:  2016        PMID： 27162744      PMCID： PMC4853367          DOI： 10.18240/ijo.2016.04.29

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  4 in total

1.  Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir.

Authors:  Richard H Roe; J Michael Jumper; Vincent Gualino; Jon Wender; H Richard McDonald; Robert N Johnson; Arthur D Fu; Emmett T Cunningham
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

Review 2.  Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.

Authors:  Robert K Zeldin; Richard A Petruschke
Journal:  J Antimicrob Chemother       Date:  2003-12-04       Impact factor: 5.790

Review 3.  Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature.

Authors:  Chiara M Eandi; Piergiorgio Neri; Ron A Adelman; Lawrence A Yannuzzi; Emmett T Cunningham
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

4.  Spectral-domain optical coherence tomography features of acute syphilitic posterior placoid chorioretinitis: the role of autoimmune response in pathogenesis.

Authors:  Pedro Brito; Susana Penas; Angela Carneiro; Jorge Palmares; F Falcão Reis
Journal:  Case Rep Ophthalmol       Date:  2011-01-25
  4 in total
  6 in total

Review 1.  An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment.

Authors:  Dragana Javorac; Lazar Grahovac; Luka Manić; Nikola Stojilković; Milena Anđelković; Zorica Bulat; Danijela Đukić-Ćosić; Marijana Curcic; Aleksandra Buha Djordjevic
Journal:  Food Chem Toxicol       Date:  2020-07-21       Impact factor: 6.023

2.  Revealing the toxicity of lopinavir- and ritonavir-containing water and wastewater treated by photo-induced processes to Danio rerio and Allivibrio fischeri.

Authors:  Bożena Czech; Agnieszka Krzyszczak; Anna Boguszewska-Czubara; Grzegorz Opielak; Izabela Jośko; Mirabbos Hojamberdiev
Journal:  Sci Total Environ       Date:  2022-02-17       Impact factor: 10.753

3.  Case Report: Multimodal Imaging of Toxic Retinopathies Related to Human Immunodeficiency Virus Antiretroviral Therapies: Maculopathy vs. Peripheral Retinopathy. Report of Two Cases and Review of the Literature.

Authors:  Arthur Hammer; François-Xavier Borruat
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

Review 4.  Management of Antiretroviral Therapy with Boosted Protease Inhibitors-Darunavir/Ritonavir or Darunavir/Cobicistat.

Authors:  Ruxandra-Cristina Marin; Tapan Behl; Nicoleta Negrut; Simona Bungau
Journal:  Biomedicines       Date:  2021-03-18

Review 5.  COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach.

Authors:  Soha R Abd El Hadi; Esmat E Zien El-Deen; Mostafa M Bahaa; Abdelfattah A Sadakah; Heba A Yassin
Journal:  Drug Des Devel Ther       Date:  2021-07-30       Impact factor: 4.162

Review 6.  Drug repurposing approach to fight COVID-19.

Authors:  Thakur Uttam Singh; Subhashree Parida; Madhu Cholenahalli Lingaraju; Manickam Kesavan; Dinesh Kumar; Raj Kumar Singh
Journal:  Pharmacol Rep       Date:  2020-09-05       Impact factor: 3.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.